Igor Khandros

Co-Founder & Chief Executive Officer at Nutcracker Therapeutics, Inc.

Igor Khandros

Igor Khandros

Co-Founder & Chief Executive Officer at Nutcracker Therapeutics, Inc.

Overview
Career Highlights

Nutcracker Therapeutics, Inc.
Berkeleyside
Berkeley Lights, Inc.

RelSci Relationships

239

Number of Boards

4

Birthday

1955

Age

66

Relationships
RelSci Relationships are individuals Igor Khandros likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Berkeley Lights, Inc.

Relationship likelihood: Strong

Professor of Electrical Engineering at University of California - Berkeley

Relationship likelihood: Strong

Partner Emeritus at Mohr Davidow Ventures

Relationship likelihood: Strong

Co-Founder at Cityside

Relationship likelihood: Strong

Co-Founder at Cityside

Relationship likelihood: Strong

General Counsel at Berkeley Lights, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at The Bronson Group LLC

Relationship likelihood: Strong

Former Chief Executive Officer, President & Director at FormFactor Inc.

Relationship likelihood: Strong

Chief Operating Officer at Atonarp, Inc.

Relationship likelihood: Strong

Chairman of the Department of Cell Biology at Yale University - Yale School of Medicine

Relationship likelihood: Strong

Paths to Igor Khandros
Potential Connections via
Relationship Science
You
Igor Khandros
Co-Founder & Chief Executive Officer at Nutcracker Therapeutics, Inc.
Education
MS in Metallurgical Engineering

Today Kyiv Polytechnic Institute is the largest institution of higher education in Ukraine. Given the large organizational role Kiev Polytechnic Institute in the preparation of engineering and scientific personnel, by the decree of President of Ukraine 289/95 of 8 April 1995 ''On the Kyiv Polytechnic Institute'' it was given the status of National Technical University of Ukraine.

PhD in Metallurgy

Stevens Institute of Technology The Innovation University®, is a premier, private research university situated in Hoboken, N.J. overlooking the Manhattan skyline. Founded in 1870, technological innovation has been the hallmark and legacy of Stevens’ education and research programs for more than 140 years. Within the university’s three schools and one college, more than 6,100 undergraduate and graduate students collaborate with more than 350 faculty members in an interdisciplinary, student-centric, entrepreneurial environment to advance the frontiers of science and leverage technology to confront global challenges. Stevens is home to three national research centers of excellence, as well as joint research programs focused on critical industries such as healthcare, energy, finance, defense and STEM education. The university is the fastest-rising college in the U.S. News & World Report ranking of the best national universities, and it is consistently ranked among the nation’s elite for return on investment for students, career services programs, and mid-career salaries of alumni. Stevens is in the midst of a 10-year strategic plan, The Future. Ours to Create., designed to further extend the Stevens legacy to create a forward-looking and far-reaching institution with global impact

Career History
Co-Founder & Chief Executive Officer
Current

Nutcracker Therapeutics is a biotech company that develops and produces mRNA therapeutics on its proprietary, microfluidic, and biochip-based platform. The company specializes in a fully-integrated system for the production of mRNA-therapeutics at the push of a button that enables scalable on-demand experimental and manufacturing capacity, thereby enabling healthcare companies to produce complex multimodal therapeutics at point of care. Nutcracker Therapeutics combines the productivity of RNA biology with innovations inspired by semiconductor manufacturing techniques to develop a proprietary miniaturized platform that enables the rapid discovery, development, and manufacturing of mRNA therapies and vaccines. Its ACORN platform is a first-of-its-kind, computer-controlled RNA manufacturing system that starts with a nucleic acid sequence of interest and produces optimized nanoparticle-encapsulated RNA therapeutics on dedicated, single-use biochips. Igor Khandros and Benjamin Eldridge established the company in Emeryville, California in 2017.

Co-Founder
Tenure Unconfirmed

Berkeleyside is an independent local news website that offers breaking news and reporting on Berkeley's diversity of issues, people, food, and more. It covers the diversity of people, issues, events, food, and environment in its city, whose impact reaches far beyond the Bay Area. As a professional in the field of online local journalism, Berkeleyside benefits from its large community of engaged readers. Berkeleyside averages 160,000 unique visitors a month, and 565,000 pageviews. It was the winner of the Society of Professional Journalists Northern California Excellence in Journalism Award for Community Journalism in both 2013 and 2014. Launched in 2009, Berkeleyside was founded by three veteran journalists, namely Lance Knobel, Tracey Taylor, and Frances Dinkelspiel. It is based in Berkeley, C.A.

Co-Founder, Director
2011 - 2017

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. t operates through the the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Political Donations
$1,000
1999

Former Senator from New Jersey

Transactions
Details Hidden

Berkeley Lights, Inc. issued USD Common Stock

Investments
Details Hidden

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. t operates through the the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Details Hidden

FormFactor, Inc. engages in the provision of test and measurement solutions. It operates through the following segments: Probe Cards and Systems. The Probe Cards segment consists of technologies and product architectures, including micro-electromechanical systems technologies. The Systems segment comprises of analytical probe solutions for on-wafer probing, board test, and package test. FormFactor was founded by Igor Khandros on April 15, 1993 and is headquartered in Livermore, CA.

Public Holdings
Restricted data only for RelSci Enterprise users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Igor Khandros. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Igor Khandros's profile does not indicate a business or promotional relationship of any kind between RelSci and Igor Khandros.